Business Wire

P&G: Pantene Japan Launched the Advertising Campaign "#HairWeGo My Hair Moves Me Forward"

Jaa

Pantene Japan (Headquarters: Kobe City) launched the adverting campaign “#HairWeGo My Hair Moves Me Forward” in the Japanese national newspaper “Asahi Shimbun” on January 7th, 2019 featuring Ms. Sato Kondo and babychanco. Pantene Japan selected Ms. Sato Kondo who is the first ever gray hair advertising ambassador for Pantene Japan and Japanese baby girl called babychanco known as full head of voluminous hair all over the world who both attracted attention with their own style of expressing themselves through their hair in 2018.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190108006168/en/

Sato Kondo (Photo: Business Wire)

Sato Kondo (Photo: Business Wire)

Summary of the Advertisement

Newspaper advertisement:
January 7th, 2019 (Monday) Asahi Shimbun Newspaper morning edition

Advertisement image DL: https://bit.ly/2s7xIIx

Pantene Official Twitter: @PanteneJapan

Pantene Official Instagram: @pantene_en_official

The Message of the Advertisement

In 2019, let your hair move you forward. From the time we were born, we’ve lived our lives feeling a little anxious about being different and constantly comparing ourselves to others. Somehow, we grew up believing that it’s better to be the same as everyone else, without really understanding why. However, in 2018, Sato Kondo, who proudly lives without coloring or hiding her grey hair, won the admiration of many women.
Japanese baby girl “babychanco” who has full head of voluminous hair, received love from people all over the world. In some way or other, these two may have taught us the importance of expressing our true selves.
In 2019, We hope many more women will take a step forward towards who they want to be. Pantene Japan celebrates all women in taking that first step forward towards who they want to be.

The Special Birthday Movie for babychanco

Pantene Japan sent the short movie titled “The Hairy Tale by babychanco #HairWeGo PANTENE” on December 23rd, 2018 which was the babychanco’s 1st year birthday. The movie features the memory of babychanco's one year from her birth who is well known all over the world as full head of voluminous hair. Looking back at her various hair episodes with our celebration greetings, the story encourages viewers to embrace their own individuality and difference.

This babychanco project started by chance when one of the team member of Pantene found a magazine article about her. The U.S. weekly magazine “People” introduced the baby girl with a comment, "Get this kid a Pantene ad!” babychanco’s unique natural born voluminous hair has been inspiring people around the world to love themselves and to embrace difference which overlaps with the Pantene Japan's brand message,“#HairWeGo My hair moves me forward.”

Movie title: The Hairy Tale by babychanco #HairWeGo PANTENE
Launch timing: December 23rd, 2018
Movie URL (English version) : https://youtu.be/zqF41BUKLy8 (youtube)

Pantene Japan Supports All Women Through Their Own Beautiful Hair.

Pantene Japan has a philosophy "Great hair gives women the courage to take a step forward". We hope many more women will move forward towards who they want to be. Pantene Japan will keep supporting all women who step forward with their beautiful hair.

The Profile of Ms. Sato Kondo

July 11, 1968 born in Gifu prefecture.
Started career from Fuji TV. Assigned many kinds of TV program such as information and comedies with her calm voice.
As a special professor of the department of broadcasting at Nihon University College of Arts, teaching announcement practice, recitation, graduation research guidance from 2011.

The Profile of babychanco

Born in Kyoto Prefecture in December 2017.
She became popular all over the world when she was at the age of 4 months when her mother started post her pictures in Instagram at the age of 4 months. Her followers are over 300,000 in 7 months from first posting. Many of her fans are attracted not only her unique voluminous hair but also her prettiness. Shown with many of domestic TV medias and picked up in overseas magazine "People".

Contact information

For inquiries on this release or its publication:
VECTOR INC.
Akari Suda
Takeshi Shimizu
pantene-pr@vectorinc.co.jp

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Vertex Announces European Commission Approval for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease21.1.2019 12:00Tiedote

Vertex Pharmaceuticals (Europe) Limited today announced that the European Commission has granted approval of the label extension for ORKAMBI® (lumacaftor/ivacaftor) for the treatment of children with cystic fibrosis (CF) aged 2 to 5 years old who have two copies of the F508del mutation, the most common form of the disease. “Today’s approval by the European Commission brings us one step closer to our goal of bringing treatment to all people living with CF,” said Reshma Kewalramani, MD, Executive Vice President, Global Medicines Development and Medical Affairs and Chief Medical Officer at Vertex. ‘‘By treating the underlying cause of disease early, we can potentially modify its course and offer patients the chance of improved outcomes.’’ The label update is based on data from a Phase 3 open-label safety study in 60 patients that showed treatment with lumacaftor/ivacaftor was generally well tolerated for 24 weeks, with a safety profile in these pediatric patients generally consistent with

Anticipation Builds as MWC19 Barcelona Approaches21.1.2019 12:00Tiedote

The GSMA today announced final updates for MWC19 Barcelona (formerly Mobile World Congress), including additional keynote speakers, participating companies, programmes and events. Taking place 25-28 February 2019, with events being staged at Fira Gran Via, Fira Montjuïc and La Farga L’Hospitalet, MWC19 Barcelona is set to attract more than 107,000 professionals from over 200 countries and territories. “With the anticipated arrival of 5G, this year’s event is set to be one of the most exciting as the industry convenes to showcase Intelligent Connectivity across new technologies on the brink of reaching millions of people across the world,” said John Hoffman, CEO, GSMA Ltd. “Over the four days of MWC19, attendees will have the opportunity to hear from leaders who are driving innovation and we look forward once again to welcoming the mobile world to Barcelona.” Global Leaders to Keynote The GSMA announced the addition of several new keynote speakers for MWC19 including executives from lea

B2C2 Launches Streaming OTC Pricing with Point-and-Click Execution21.1.2019 12:00Tiedote

B2C2, one of the largest cryptocurrency liquidity providers and the leader in electronic OTC trading, today announced the launch of streaming pricing with point-and-click execution on its OTC platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190121005063/en/ Max Boonen, Founder and CEO of B2C2 (Photo: Business Wire) For the first time, B2C2’s clients will be able to view and execute trades on a real-time two-way market, via the firm’s secure web interface. The new functionality allows market participants to easily monitor live pricing in user-defined quantities and execute with the click of a button, as they would on traditional FX trading platforms. The launch rounds out a number of milestones for B2C2 in 2018, including surpassing 2017 peak volumes; rolling out a completely redesigned front-end; forming integration partnerships with the major liquidity hubs; and launching a research offering. Founded in 2015, B2C2 i

Alnylam Pharmaceuticals and Medison Pharma Partner to Commercialize RNAi Therapeutics in Israel21.1.2019 11:00Tiedote

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma, Israel’s leading commercial partner for innovative pharmaceuticals, announced today an exclusive agreement to commercialize ONPATTRO®, the first-ever commercialized RNAi therapeutic, as well as other investigational therapeutics under development in the Alnylam RNAi portfolio. “Our partnership with Medison marks an important step in our global commercial expansion and signals our intent to ensure that patients suffering from serious rare diseases have access to our medicines, regardless of location,” said Theresa Heggie, SVP and Head of Europe, Middle East and Africa, and Canada, Alnylam Pharmaceuticals. “Medison has a strong organization with a proven track record of commercializing orphan products successfully, together with an infrastructure uniquely suited to supporting patients suffering from rare diseases in Israel and providing access to our potentially transformational thera

Gore Introduces GORE® TAG® Conformable Thoracic Stent Graft with Reduced Profiles in Europe21.1.2019 11:00Tiedote

W. L. Gore & Associates, Inc. (Gore) today introduced reduced profiles for the most commonly used diameters of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System. The reduced profile allows physicians to perform TEVAR in patients with smaller vessels where access is challenging and aortic anatomy is tortuous, expanding the availability of Gore’s thoracic stent graft to a greater population of patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190121005042/en/ GORE(R) TAG(R) Conformable Thoracic Stent Graft with ACTIVE CONTROL System (Photo: Business Wire) The GORE® TAG® Conformable Thoracic Stent Graft was modified to reduce the delivery profile of the 31, 37, and 40 mm device diameters by 2 Fr for all lengths. The reduction in profile, through the use of a smaller diameter primary sleeve, is the only change to the device. The stent graft leverages the same predictable outcomes of the time-teste

HCL 2030 Ecosystem Platform to Explore Societal Implications of Emerging Technology at the World Economic Forum21.1.2019 10:26Tiedote

HCL Technologies (HCL), a leading global technology company and the World Economic Forum’s Strategic Partner, today announced its largest presence to date at the side-lines of World Economic Forum’s Annual Meeting in Davos scheduled from 21st January 2019 to 25th January 2019. The company will host a three-day event in a special Pavilion that will feature a technology showcase, thought-leadership programs, as well as a number of high-level networking and social events throughout the tenure of the conference. The overarching theme of the HCL and Fast Company programs will explore how humanity’s relationship with technology will evolve through the next decade of rapid innovation. HCL has partnered with Fast Company to develop a thought-leadership track that includes three panel discussion breakfasts. As part of the theme of Human-Machine Harmony, HCL is launching the HCL 2030 Platform, together with its ecosystem of partners and stakeholders, that will conduct in-depth explorations and d

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme